100 related articles for article (PubMed ID: 16704917)
1. Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without P. Jiroveci infection.
Angelici E; Spezzano M; Vaccari S; Valentini SB; Romani R; Contini C; Canipari R
Microb Pathog; 2006 Jul; 41(1):1-9. PubMed ID: 16704917
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii.
Angelici E; Contini C; Carfagna P; Romani R; Magno MS; Serra P; Canipari R
J Eukaryot Microbiol; 2001; Suppl():150S-151S. PubMed ID: 11906036
[No Abstract] [Full Text] [Related]
3. Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia.
Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
Microbiol Immunol; 2001; 45(8):605-11. PubMed ID: 11592634
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
Elia C; Cassol E; Sidenius N; Blasi F; Castagna A; Poli G; Alfano M
J Leukoc Biol; 2007 Nov; 82(5):1212-20. PubMed ID: 17704294
[TBL] [Abstract][Full Text] [Related]
5. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
[TBL] [Abstract][Full Text] [Related]
7. Role of urokinase in the activation of macrophage-associated TGF-beta in silica-induced lung fibrosis.
Matrat M; Lardot C; Huaux F; Broeckaert F; Lison D
J Toxicol Environ Health A; 1998 Nov; 55(5):359-71. PubMed ID: 9829559
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction.
Mojsilović SS; Santibanez JF
Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879
[TBL] [Abstract][Full Text] [Related]
10. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.
Handley MA; Steigbigel RT; Morrison SA
J Virol; 1996 Jul; 70(7):4451-6. PubMed ID: 8676469
[TBL] [Abstract][Full Text] [Related]
11. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel inhibits transforming growth factor-β-increased urokinase-type plasminogen activator expression through p38 MAPK and RAW 264.7 macrophage migration.
Mojsilovic S; Tosic M; Mojsilovic S; Zivanovic M; Bjelica S; Srdic Rajic T; F Santibanez J
J BUON; 2020; 25(2):1257-1265. PubMed ID: 32521934
[TBL] [Abstract][Full Text] [Related]
14. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
15. Estramustine Phosphate Inhibits TGF-
Mojsilovic SS; Mojsilovic S; Bjelica S; Santibanez JF
Anal Cell Pathol (Amst); 2018; 2018():3134102. PubMed ID: 30245956
[TBL] [Abstract][Full Text] [Related]
16. Characterization of latent TGF-beta activation by murine peritoneal macrophages.
Nunes I; Shapiro RL; Rifkin DB
J Immunol; 1995 Aug; 155(3):1450-9. PubMed ID: 7636210
[TBL] [Abstract][Full Text] [Related]
17. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
18. Modulation of urokinase-type plasminogen activator by transforming growth factor beta1 in acetaldehyde-activated hepatic stellate cells.
Pérez-Liz G; Flores-Hernández J; Arias-Montaño JA; Reyes-Esparza JA; Rodríguez-Fragoso L
Pharmacology; 2005 Jan; 73(1):23-30. PubMed ID: 15452360
[TBL] [Abstract][Full Text] [Related]
19. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
[TBL] [Abstract][Full Text] [Related]
20. [Pneumocystis jiroveci pneumonia: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients].
Cerón I; Rabagliati R; Langhaus J; Silva F; Guzmán AM; Lagos M
Rev Chilena Infectol; 2014 Aug; 31(4):417-24. PubMed ID: 25327195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
